[go: up one dir, main page]

DE60234586D1 - Nsaid-formulierung enthaltend eine granulöse zusammensetzung und eine extragranulöse zusammensetzung - Google Patents

Nsaid-formulierung enthaltend eine granulöse zusammensetzung und eine extragranulöse zusammensetzung

Info

Publication number
DE60234586D1
DE60234586D1 DE60234586T DE60234586T DE60234586D1 DE 60234586 D1 DE60234586 D1 DE 60234586D1 DE 60234586 T DE60234586 T DE 60234586T DE 60234586 T DE60234586 T DE 60234586T DE 60234586 D1 DE60234586 D1 DE 60234586D1
Authority
DE
Germany
Prior art keywords
composition
formulation contains
extragranular
granular
nsaid formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60234586T
Other languages
English (en)
Inventor
Tracey Jane Rhoades
Robert Arthur Sherry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reckitt Benckiser Healthcare UK Ltd
Original Assignee
Reckitt Benckiser Healthcare UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt Benckiser Healthcare UK Ltd filed Critical Reckitt Benckiser Healthcare UK Ltd
Application granted granted Critical
Publication of DE60234586D1 publication Critical patent/DE60234586D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60234586T 2001-06-07 2002-05-30 Nsaid-formulierung enthaltend eine granulöse zusammensetzung und eine extragranulöse zusammensetzung Expired - Lifetime DE60234586D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0113839.5A GB0113839D0 (en) 2001-06-07 2001-06-07 Therapeutic agents
PCT/GB2002/002536 WO2002098392A1 (en) 2001-06-07 2002-05-30 Nsaid formulation comprising a granular composition and an extra-granular composition

Publications (1)

Publication Number Publication Date
DE60234586D1 true DE60234586D1 (de) 2010-01-14

Family

ID=9916080

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60234586T Expired - Lifetime DE60234586D1 (de) 2001-06-07 2002-05-30 Nsaid-formulierung enthaltend eine granulöse zusammensetzung und eine extragranulöse zusammensetzung

Country Status (16)

Country Link
US (1) US20050106235A1 (de)
EP (1) EP1392249B1 (de)
JP (1) JP2004532270A (de)
AR (1) AR034436A1 (de)
AT (1) ATE450255T1 (de)
AU (1) AU2002302786B2 (de)
CA (1) CA2449352C (de)
CZ (1) CZ303694B6 (de)
DE (1) DE60234586D1 (de)
ES (1) ES2335976T3 (de)
GB (1) GB0113839D0 (de)
PL (1) PL213979B1 (de)
PT (1) PT1392249E (de)
RU (1) RU2298404C2 (de)
SK (1) SK52004A3 (de)
WO (1) WO2002098392A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0113841D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
GB0312419D0 (en) * 2003-05-30 2003-07-02 Boots Healthcare Int Ltd Use of a compound in the treatment of sleep disorders and the like, in providing refreshedness on waking and a method for the treatment of grogginess
GB0423103D0 (en) * 2004-10-19 2004-11-17 Boots Healthcare Int Ltd Therapeutic agents
CA2589079A1 (en) * 2004-11-03 2006-06-01 Equitech Corporation Nsaid compositions exhibiting clinical superiority
ZA200806138B (en) * 2005-12-16 2009-11-25 Hanmi Pharm Ind Co Ltd Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same
EP2307022A4 (de) * 2007-10-31 2011-08-24 Equitech Corp Verbesserte nsaid-formulierungen
RU2378003C1 (ru) * 2008-06-06 2010-01-10 Сергей Юрьевич Лешков Фармацевтическая композиция на основе экстракта зеленой ягоды кофе, способ получения и применения
WO2011001228A1 (en) * 2008-08-14 2011-01-06 Shasun Chemicals And Drugs Limited Aryl alkyl carboxylic acid salts, process for preparation and dosage forms
US20110064813A1 (en) * 2009-09-16 2011-03-17 Charles Vaughn Use of salsalate with or without caffeine and with or without omega 3, and other pharmaceutical compounds in a distinctively unique nano-particulate capsule and tablet
EP2704696A1 (de) 2012-03-26 2014-03-12 Glatt AG Geschmacksmaskierte ibuprofenkörnchen
WO2014194872A1 (en) * 2013-06-04 2014-12-11 Zentiva, K.S. Taste masking of water soluble drugs using poloxamers
BR112017003425A2 (pt) * 2014-08-28 2017-11-28 Sanofi Aventis De Mexico Sa De Cv composição farmacêutica para o tratamento de dor dentária ou mandibular aguda
BE1023057B1 (nl) * 2016-06-06 2016-11-16 Nordic Specialty Pharma Bvba Ibuprofen tablet
WO2024237986A1 (en) * 2023-05-15 2024-11-21 Dow Global Technologies Llc Spray dried excipient blends

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3437917A1 (de) * 1984-10-17 1986-04-17 Bayer Ag, 5090 Leverkusen Kombination von dihydropyridinen mit ace-hemmern sowie ihre verwendung in arzneimitteln
DE3639038C2 (de) * 1986-11-14 1997-02-06 Helmut Dr Lukas Verwendung von S-(+)-Ibuprofen zur schnellen Behandlung humaner Schmerzen
SE463541B (sv) * 1987-08-31 1990-12-10 Lejus Medical Ab Granulaer produkt oeverdragen av en smaelta av sig sjaelv samt foerfarande foer dess framstaellning
US5256699A (en) * 1988-10-18 1993-10-26 Ciba-Geify Corporation Dispersible tablet formulation of diclofenac acid free base
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
US5429825A (en) * 1992-06-26 1995-07-04 Mcneil-Ppc, Inc. Rotomelt granulation
US5512300A (en) * 1992-09-15 1996-04-30 Warner-Lambert Company Prevention of ibuprofen from forming low melting eutectics with other therapeutic agents in solid dosage forms
US5370878A (en) * 1993-09-30 1994-12-06 Hallmark Pharmaceuticals, Inc. Method for preparing a direct compression granulated acetaminophen composition
DK0812589T3 (da) * 1993-12-10 2000-11-13 Fujisawa Pharmaceutical Co Kombineret antipyretisk og analgetisk lægemiddel
AT401871B (de) * 1994-01-28 1996-12-27 Gebro Broschek Gmbh Verfahren zur herstellung von s(+)-ibuprofen- partikeln mit verbesserten fliesseigenschaften und deren verwendung zur arzneimittelherstellung
DE4418837A1 (de) * 1994-05-30 1995-12-07 Bayer Ag Thermisches Granulierverfahren
US5683720A (en) * 1994-10-28 1997-11-04 Fuisz Technologies Ltd. Liquiflash particles and method of making same
US5997590A (en) * 1996-11-13 1999-12-07 Quantum Energy Technologies Corp. Stabilized water nanocluster-fuel emulsions designed through quantum chemistry
US6013280A (en) * 1997-10-07 2000-01-11 Fuisz Technologies Ltd. Immediate release dosage forms containing microspheres
US6117451A (en) * 1998-08-25 2000-09-12 Pharmalogix, Inc. Direct compression metformin hydrochloride tablets
WO2001041733A2 (en) * 1999-12-09 2001-06-14 The Boots Company Plc Compressed tablet composition comprising a nsaid

Also Published As

Publication number Publication date
PL366892A1 (en) 2005-02-07
AR034436A1 (es) 2004-02-25
CZ303694B6 (cs) 2013-03-20
GB0113839D0 (en) 2001-08-01
WO2002098392A1 (en) 2002-12-12
JP2004532270A (ja) 2004-10-21
RU2298404C2 (ru) 2007-05-10
PL213979B1 (pl) 2013-05-31
US20050106235A1 (en) 2005-05-19
EP1392249B1 (de) 2009-12-02
CA2449352C (en) 2010-11-30
SK52004A3 (en) 2004-07-07
CA2449352A1 (en) 2002-12-12
ES2335976T3 (es) 2010-04-07
PT1392249E (pt) 2010-02-04
CZ200427A3 (cs) 2005-02-16
ATE450255T1 (de) 2009-12-15
AU2002302786B2 (en) 2007-01-18
EP1392249A1 (de) 2004-03-03
RU2003135631A (ru) 2005-01-20

Similar Documents

Publication Publication Date Title
HUP0303434A3 (en) Atorvastatin calcium in a pharmaceutical form, composition thereof, and pharmaceutical formulation comprising atorvastatin calcium
NO20033384L (no) Farmasoytisk formulering
IL158523A0 (en) Epothilone derivatives and pharmaceutical compositions containing the same
DE60109335D1 (de) Silikonverbindung und eine Make-up-Zusammensetzung
DE60212102D1 (de) Eine vernetzbare polyethylenzusammensetzung
IL155196A0 (en) Benzamide derivatives and pharmaceutical compositions containing the same
PL367180A1 (pl) Trwała kompozycja farmaceutyczna
ATE307571T1 (de) Pharmazeutische formulierung enthaltend bicalutamid
DE60234586D1 (de) Nsaid-formulierung enthaltend eine granulöse zusammensetzung und eine extragranulöse zusammensetzung
DE60232963D1 (de) Oral anzuwendende zuckerkrankheitshemmende "einmal täglich" arzneizusammensetzung enthaltend eine biguanidverbindung und zumindestens einen anderen wirkstoff
NO20035627D0 (no) Farmasöytisk formulering
GB0108470D0 (en) Pharmaceutical compositions and their use
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
DK1361791T3 (da) Agrokemisk formulering
ATE447964T1 (de) Eine pharmazeutische formulierung, enthaltend einen inhibitor der carboxypeptidase a und einen thrombin-inhibitor
NO20042475L (no) Farmasoytiske blandinger inneholdende 3,4-propinoperhydropuriner og anvendelser for blokkering av neuronal transmisjon
DE60225446D1 (de) Flammgeschützte zusammensetzung und artikel
DE10291905D2 (de) Pharmazeutische Zusammensetzung
ATE350029T1 (de) Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
DE60137952D1 (de) Pharmazeutische zusammensetzungen mit epinastin und pseudoephedrin
ATE338548T1 (de) Pyridoindolonderivate und antikrebsmittel enthaltende pharmazeutische mischungen
ATE279927T1 (de) Pharmazeutische zusammensetzungen enthaltend tobramycin und xanthangummi
DE60317719D1 (de) Kosmetische und pharmazeutische zusammensetzungen mit lycopin
DE10107261B4 (de) Pharmazeutische Zusammensetzung
EE200300563A (et) Bensüülaminopürimidiiniühendid, nende kasutamine ja ravim

Legal Events

Date Code Title Description
8364 No opposition during term of opposition